| GTO ID | GTC3579 |
| Trial ID | NCT06026774 |
| Disease | Gastrointestinal System Cancer |
| Therapy | mRNA vaccine |
| Treatment | iNeo-Vac-R01 |
| Co-treatment | standard adjuvant therapy |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Clinical Study to Assess the Safety, Feasibility, and Efficacy of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard Adjuvant Therapy in Subjects With Resected Digestive System Neoplasms |
| Year | 2023 |
| Country | China |
| Company sponsor | Sir Run Run Shaw Hospital |
| Other ID(s) | SRRSH2023-755-03 |
| Cohort 1 | |||||||||
|
|||||||||